Back to Journals » Drug Design, Development and Therapy » Volume 16

Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity

Total article views   HTML views PDF downloads Totals
6,159 Dovepress* 5,955+ 260 6,215
PubMed Central* 204 89 293
Totals 6,159 349 6,508
*Since 11 August 2022
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar